NCT01663376View on ClinicalTrials.gov

Safety and Effect of Adipose Tissue Derived Mesenchymal Stem Cells Implantation in Patients With Critical Limb Ischemia

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

April 30, 2011

Conditions
Critical Limb Ischemia
Interventions
PROCEDURE

Autologous Adipose Tissue derived MSCs Transplantation

Intramuscular injection of Autologous Adipose Derived Mesenchymal Stem Cells. Dose : 1x10e8 \~3x10e8 cells

Trial Locations (1)

Unknown

Pusan National University Hospital, Pusan

Sponsors

Lead Sponsor

R-Bio
All Listed Sponsors
collaborator

Pusan National University Hospital

OTHER

lead

R-Bio

INDUSTRY

NCT01663376 - Safety and Effect of Adipose Tissue Derived Mesenchymal Stem Cells Implantation in Patients With Critical Limb Ischemia | Biotech Hunter | Biotech Hunter